Primary CNS lymphoma (PCNSL) is a rare form of non-Hodgkin lymphoma that affects the central nervous system, including the brain, spinal cord, and eyes. Unlike other lymphomas, it primarily manifests within the brain, leading to symptoms such as headaches, cognitive dysfunction, and vision problems. Research on PCNSL focuses on understanding its unique biology and developing targeted therapies due to its limited response to traditional treatments like chemotherapy. Recent studies delve into the genetic mutations driving its growth and potential immunotherapies that harness the body's immune system to fight cancer cells specifically within the CNS. By unraveling the intricacies of PCNSL, researchers aim to improve diagnostic methods and devise more effective treatment strategies tailored to this challenging disease.
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States